172 related articles for article (PubMed ID: 34576139)
1. Deletion of
Martínez-Nieto G; Heljasvaara R; Heikkinen A; Kaski HK; Devarajan R; Rinne O; Henriksson C; Thomson E; von Hertzen C; Miinalainen I; Ruotsalainen H; Pihlajaniemi T; Karppinen SM
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576139
[TBL] [Abstract][Full Text] [Related]
2. Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth.
Mao SPH; Park M; Cabrera RM; Christin JR; Karagiannis GS; Oktay MH; Zaiss DMW; Abrams SI; Guo W; Condeelis JS; Kenny PA; Segall JE
Breast Cancer Res; 2018 Oct; 20(1):131. PubMed ID: 30367629
[TBL] [Abstract][Full Text] [Related]
3. MRCKα Is Dispensable for Breast Cancer Development in the MMTV-PyMT Model.
Kwa MQ; Brandao R; Phung TH; Ge J; Scieri G; Brakebusch C
Cells; 2021 Apr; 10(4):. PubMed ID: 33921698
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase 13 is induced in fibroblasts in polyomavirus middle T antigen-driven mammary carcinoma without influencing tumor progression.
Nielsen BS; Egeblad M; Rank F; Askautrud HA; Pennington CJ; Pedersen TX; Christensen IJ; Edwards DR; Werb Z; Lund LR
PLoS One; 2008 Aug; 3(8):e2959. PubMed ID: 18698413
[TBL] [Abstract][Full Text] [Related]
5. The chemokine receptor CCR6 facilitates the onset of mammary neoplasia in the MMTV-PyMT mouse model via recruitment of tumor-promoting macrophages.
Boyle ST; Faulkner JW; McColl SR; Kochetkova M
Mol Cancer; 2015 Jun; 14():115. PubMed ID: 26047945
[TBL] [Abstract][Full Text] [Related]
6. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
7. Hic-5 remodeling of the stromal matrix promotes breast tumor progression.
Goreczny GJ; Ouderkirk-Pecone JL; Olson EC; Krendel M; Turner CE
Oncogene; 2017 May; 36(19):2693-2703. PubMed ID: 27893716
[TBL] [Abstract][Full Text] [Related]
8. Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer.
Wallace JA; Li F; Balakrishnan S; Cantemir-Stone CZ; Pecot T; Martin C; Kladney RD; Sharma SM; Trimboli AJ; Fernandez SA; Yu L; Rosol TJ; Stromberg PC; Lesurf R; Hallett M; Park M; Leone G; Ostrowski MC
PLoS One; 2013; 8(8):e71533. PubMed ID: 23977064
[TBL] [Abstract][Full Text] [Related]
9. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
[TBL] [Abstract][Full Text] [Related]
10. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
[TBL] [Abstract][Full Text] [Related]
11. COX-2 modulates mammary tumor progression in response to collagen density.
Esbona K; Inman D; Saha S; Jeffery J; Schedin P; Wilke L; Keely P
Breast Cancer Res; 2016 Mar; 18(1):35. PubMed ID: 27000374
[TBL] [Abstract][Full Text] [Related]
12. Adipose monocyte chemotactic protein-1 deficiency reduces high-fat diet-enhanced mammary tumorigenesis in MMTV-PyMT mice.
Sundaram S; Yan L
J Nutr Biochem; 2020 Mar; 77():108313. PubMed ID: 31837540
[TBL] [Abstract][Full Text] [Related]
13. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
[TBL] [Abstract][Full Text] [Related]
14. Bisected, complex N-glycans and galectins in mouse mammary tumor progression and human breast cancer.
Miwa HE; Koba WR; Fine EJ; Giricz O; Kenny PA; Stanley P
Glycobiology; 2013 Dec; 23(12):1477-90. PubMed ID: 24037315
[TBL] [Abstract][Full Text] [Related]
15. Anti-matrix metalloproteinase-9 DNAzyme decreases tumor growth in the MMTV-PyMT mouse model of breast cancer.
Hallett MA; Teng B; Hasegawa H; Schwab LP; Seagroves TN; Pourmotabbed T
Breast Cancer Res; 2013 Feb; 15(1):R12. PubMed ID: 23407024
[TBL] [Abstract][Full Text] [Related]
16. Presence of mouse mammary tumour-like virus gene sequences may be associated with morphology of specific human breast cancer.
Lawson JS; Tran DD; Carpenter E; Ford CE; Rawlinson WD; Whitaker NJ; Delprado W
J Clin Pathol; 2006 Dec; 59(12):1287-92. PubMed ID: 16698952
[TBL] [Abstract][Full Text] [Related]
17. ColXV Aggravates Adipocyte Apoptosis by Facilitating Abnormal Extracellular Matrix Remodeling in Mice.
Xia T; Shen Z; Cai J; Pan M; Sun C
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024006
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of vascular and progenitor cell compartments in tumours from MMTV-PyVmT transgenic mice during mammary cancer progression.
Smith MJ; Berger RW; Minhas K; Moorehead RA; Coomber BL
Int J Exp Pathol; 2011 Apr; 92(2):106-16. PubMed ID: 21059124
[TBL] [Abstract][Full Text] [Related]
19. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
[TBL] [Abstract][Full Text] [Related]
20. MDA-7/IL-24 functions as a tumor suppressor gene in vivo in transgenic mouse models of breast cancer.
Menezes ME; Shen XN; Das SK; Emdad L; Guo C; Yuan F; Li YJ; Archer MC; Zacksenhaus E; Windle JJ; Subler MA; Ben-David Y; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2015 Nov; 6(35):36928-42. PubMed ID: 26474456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]